Articles by James Calloway
Sandisk Stock Plunges 55% in July as 80% Margins Face Scrutiny
Sandisk shares have tumbled 55% in July, leaving the stock at a potential discount if its 80% margins prove sustainable, but a steep price if they erode.
Amphenol Stock Jumps 7.6% on Strong Q2 Beat and Doubled CommScope EPS Outlook
Amphenol shares rose 7.6% after Q2 earnings beat estimates and the company doubled its expected EPS benefit from the CommScope acquisition to $0.30 per share.
Bloom Energy Surges on Record Q2 Revenue, Single Client Dominates
Bloom Energy shares jumped 4.3% after posting record Q2 revenue of $1.065 billion, beating estimates. A single customer accounted for 73% of revenue, highlighting concentration risk.
GE HealthCare Stock Jumps on Record Orders, Q2 Beat
GE HealthCare shares jumped 9.9% after Q2 earnings beat estimates and orders hit a record $23.9 billion. The stock rose to $70.43 premarket, though it remains 22% below its January high.
P&G Stock Drops as 2027 Strategy Reveals Major Earnings Hurdle
P&G shares declined 3% as the fiscal 2027 outlook revealed a 9.7% pre-headwind EPS increase needed to hit guidance, overshadowing an earnings beat.
Boston Stock Falls as International Sales Counter US Cardiac Weakness
Boston Scientific shares fell 5.1% as strong international sales countered a US cardiac downturn. Q2 earnings beat estimates but guidance was cut.
Lemonade Stock Tumbles 14% as Strong Revenue Growth Fails to Lift Profit Outlook
Lemonade (NYSE:LMND) shares dropped nearly 14% in premarket trading despite a 79% revenue surge, as the company held its full-year profit forecast steady, raising concerns about risk exposure and cash flow.
Medicare Part D Subsidy Phaseout Widens Insurer Pricing Gap
CMS plans to end temporary Part D assistance after 2026, with 2027 bids up 23.7%. Insurers like Centene face enrollment risk as pricing gaps widen.
Humana Stock Tumbles 8% Premarket Despite Strong Q2, 2026 Outlook Signals Sharp H2 Loss
Humana shares dropped 8% premarket despite Q2 earnings and revenue beats, as the 2026 adjusted EPS floor of $9 implies a second-half loss of $8.91 per share.
KLA Stock Tumbles 8.7% Premarket on Cash Flow Concerns Despite Record Revenue
KLA shares fell 8.7% premarket despite record revenue and upbeat guidance, as a 23.2% drop in free cash flow raised concerns about cash conversion.
Vertiv Shares Slide on Americas Revenue Miss Despite Strong Q4 Guidance
Vertiv shares dropped 10.9% in premarket trading after Q2 revenue missed estimates by 3.1%, though adjusted EPS and cash flow exceeded expectations. Q4 guidance implies 50% year-over-year sales growth.